Portal Vein Thrombosis Prediction: Rebalanced Coagulation and Rethinking Anticoagulation

Potential conflict of interest: Nothing to report. See Article on Page 1747 It is well established that patients with cirrhosis are at an increased risk for portal vein thrombosis (PVT) and that PVT increases the risk for peritransplant death. However, it has only recently been recognized that coagulation with resultant parenchymal extinction may play a critical role in liver disease progression.1 As a result, the once firmly held dogma that...